Answers are grounded in this paper and cite their sources.
SUMMARY The use of albumin in the critical care setting is a very controversial issue. Although not a new situation, we have seen a renewed interest in this question, especially after the publication of one particular meta‐analysis. Much has been said about its publication, but it merits a brief review. Hypoalbuminemia, no longer considered to be “acceptable” or even inevitable in critically ill patients, has also been revisited. We will examine the issue by reviewing studies that have tried to correct the condition, the mechanisms by which it appears and its prognostic value. Finally, a great deal of work has been done to gain a better understanding of albumin and its properties beyond the most commonly accepted, namely maintenance of plasma oncotic pressure. A review of the research will help us to recognize that more randomized controlled trials are warranted.
No takes yet. Share an insight, caveat, or question.
Dubois et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: